Welcome to Fields Lab
Overview
Our research is focused on understanding and developing therapies for neurodegenerative diseases. We are particularly interested in how alterations in mitochondrial function and chronic inflammation interact in the neurodegenerative process. Our work includes examining postmortem brain specimens from humans and animal models to identify neuropathological signatures associated with disease. We use in vitro models to dissect neuropathogenic mechanisms and test therapeutic strategies in neurons, astrocytes, and microglia. Ultimately, the goal of our work is to identify therapeutic targets and treatments that will improve clinical outcomes for people suffering from neurological disorders.
Projects and Funding
Cannabis and Pathogenic Mechanisms Influencing Blood Brain Barrier Function in HIV | NIH R01DA058405 | Aug 15, 2024 – Jun 30, 2028.
Role: Multiple Principle Investigator
GPLD1: Association with Cognition and Amelioration through Exercise in Aging People with HIV | NIH R01AG074808 | Sep 1, 2022 – Aug 31, 2027.
Role: Co-Investigator
The role of TFAM alterations in HIV- and ART-induced mitochondrial dysfunction in the brain | NIH R01MH128108 | Jan 1, 2022 – Nov 30, 2026.
Role: Principal Investigator
Immunometabolic gene expression profiles associated with depressed mood and behavioral domains in people with HIV | NIH R01MH128869 | Sep 15, 2021 – Jun 30, 2026.
Role: Co-Investigator
Cannabis, inflammation, and the brain in persons with HIV | NIH R01DA053052 | Sep 30, 2020 – Jun 30, 2025.
Role: Co-Investigator
The role of TREM2 in Alzheimer’s disease neuropathogenesis in HIV+ individuals | NIH R56AG066215. Sep 15, 2020 – Aug 31, 2021.
Role: Principle Investigator
Mitochondrial biogenesis dysfunction in the CNS of HIV-infected individuals on antiretroviral therapy | NIH K01MH115819. Feb 1, 2018 – Jan 31, 2021.
Role: Principal Investigator
Development of Pirenzepine for HIV-SN | NIH R41NS105177. Sep 28, 2017 – Aug 31, 2019.
Role: Co-Principle Investigator
Mechanisms of mitochondrial fission/fusion dysregulation during HIV-1-associated | NIH F32NS083426. Apr 1, 2013 – Mar 31, 2015.
Role: Principle Investigator
Regulation of Astrocyte TIMP-1 in HIV-Associated Dementia | NIH F31NS072006. Apr 1, 2011 – Mar 31, 2012.
Role: Principle Investigator
2023
Ellis RJ, Marquine MJ, Kaul M, Fields JA, Schlachetzki JCM. Publisher Correction: Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management. Nat Rev Neurol. 2023 Dec;19(12):787. doi: 10.1038/s41582-023-00895-y. PubMed PMID: 37872259.
Kulbe JR, Nguyen L, Le AA, Laird AE, Taffe MA, Nguyen JD, Fields JA. Nicotine, THC, and Dolutegravir Modulate E-Cigarette-Induced Changes in Addiction- and Inflammation-Associated Genes in Rat Brains and Astrocytes. Brain Sci. 2023 Nov 7;13(11). doi: 10.3390/brainsci13111556. PubMed PMID: 38002516; PubMed Central PMCID: PMC10670019.
Kulbe JR, Le AA, Mante M, Florio J, Laird AE, Swinton MK, Rissman RA, Fields JA. GP120 and tenofovir alafenamide alter cannabinoid receptor 1 expression in hippocampus of mice. J Neurovirol. 2023 Oct;29(5):564-576. doi: 10.1007/s13365-023-01155-x. Epub 2023 Oct 6. PubMed PMID: 37801175; PubMed Central PMCID: PMC10645617.
Garces A, Martinez B, De La Garza R, Roy D, Vallee KA, Fields JA, Moore DJ, Rodrigo H, Roy U. Differential expression of interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) in Alzheimer’s disease and HIV-1 associated neurocognitive disorders. Sci Rep. 2023 Feb 25;13(1):3276. doi: 10.1038/s41598-022-27276-7. PubMed PMID: 36841839; PubMed Central PMCID: PMC9968324.
Fields JA, Swinton M, Sundermann EE, Scrivens N, Vallee KJ, Moore DJ. Complement component 3 and complement factor H protein levels are altered in brain tissues from people with human immunodeficiency virus: A pilot study. Front Aging Neurosci. 2022;14:981937. doi: 10.3389/fnagi.2022.981937. eCollection 2022. PubMed PMID: 36118688; PubMed Central PMCID: PMC9472593.
Solanky D, Fields JA, Iudicello JE, Ellis RJ, Franklin D, Clifford DB, Gelman BB, Marra CM, Morgello S, Rubin LH, Grant I, Heaton RK, Letendre SL, Mehta SR.Higher buccal mitochondrial DNA and mitochondrial common deletion number are associated with markers of neurodegeneration and inflammation in cerebrospinal fluid. J Neurovirol. 2022 Apr;28(2):281-290. doi: 10.1007/s13365-022-01052-9. Epub 2022 Feb 14. PubMed PMID: 35157246; PubMed Central PMCID: PMC9352370.
Vallee KJ, Fields JA. Caloric Restriction Mimetic 2-Deoxyglucose Reduces Inflammatory Signaling in Human Astrocytes: Implications for Therapeutic Strategies Targeting Neurodegenerative Diseases. Brain Sci. 2022 Feb 24;12(3). doi: 10.3390/brainsci12030308. PubMed PMID: 35326266; PubMed Central PMCID: PMC8945872.
Fields JA, Swinton MK, Montilla-Perez P, Ricciardelli E, Telese F. The Cannabinoid Receptor Agonist, WIN-55212-2, Suppresses the Activation of Proinflammatory Genes Induced by Interleukin 1 Beta in Human Astrocytes. Cannabis Cannabinoid Res. 2022 Feb;7(1):78-92. doi: 10.1089/can.2020.0128. Epub 2020 Dec 31. PubMed PMID: 33998879; PubMed Central PMCID: PMC8864424.
Gaskill PJ, Fields JA, Langford DT, Stauch KL, Williams DW. Editorial: Advances in Understanding NeuroHIV Associated Changes in Neuroimmune Communication in the Combined Anti-retroviral Therapy (cART) Era. Front Neurol. 2021;12:763448. doi: 10.3389/fneur.2021.763448. eCollection 2021. PubMed PMID: 34675877; PubMed Central PMCID: PMC8523985.
Swinton MK, Sundermann EE, Pedersen L, Nguyen JD, Grelotti DJ, Taffe MA, Iudicello JE, Fields JA. Alterations in Brain Cannabinoid Receptor Levels Are Associated with HIV-Associated Neurocognitive Disorders in the ART Era: Implications for Therapeutic Strategies Targeting the Endocannabinoid System.Viruses. 2021 Aug 31;13(9). doi: 10.3390/v13091742. PubMed PMID: 34578323; PubMed Central PMCID: PMC8473156.
Han MM, Frizzi KE, Ellis RJ, Calcutt NA, Fields JA. Prevention of HIV-1 TAT Protein-Induced Peripheral Neuropathy and Mitochondrial Disruption by the Antimuscarinic Pirenzepine. Front Neurol. 2021;12:663373. doi: 10.3389/fneur.2021.663373. eCollection 2021. PubMed PMID: 34211430; PubMed Central PMCID: PMC8239242.
Sundermann EE, Fields A, Saloner R, Gouaux B, Bharti A, Murphy C, Moore DJ. The utility of olfactory function in distinguishing early-stage Alzheimer’s disease from HIV-associated neurocognitive disorders. AIDS. 2021 Mar 1;35(3):429-437. doi: 10.1097/QAD.0000000000002761. PubMed PMID: 33252483; PubMed Central PMCID: PMC7856221.
Kim C, Kwon S, Iba M, Spencer B, Rockenstein E, Mante M, Adame A, Shin SJ, Fields JA, Rissman RA, Lee SJ, Masliah E. Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells. Exp Mol Med. 2021 Feb;53(2):281-290. doi: 10.1038/s12276-021-00562-6. Epub 2021 Feb 16. PubMed PMID: 33594256; PubMed Central PMCID: PMC8080790.
Saloner R, Fields JA, Marcondes MCG, Iudicello JE, von Känel S, Cherner M, Letendre SL, Kaul M, Grant I. Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior. J Neuroimmune Pharmacol. 2020 Dec;15(4):743-764. doi: 10.1007/s11481-020-09957-0. Epub 2020 Sep 15. Review. PubMed PMID: 32929575; PubMed Central PMCID: PMC7719083.
Ellis RJ, Moore DJ, Sundermann EE, Heaton RK, Mehta S, Hulgan T, Samuels D, Fields JA, Letendre SL. Nucleic acid oxidation is associated with biomarkers of neurodegeneration in CSF in people with HIV. Neurol Neuroimmunol Neuroinflamm. 2020 Nov 5;7(6). doi: 10.1212/NXI.0000000000000902. Print 2020 Nov 5. PubMed PMID: 33055205; PubMed Central PMCID: PMC7577534.
Ferrara M, Bumpus NN, Ma Q, Ellis RJ, Soontornniyomkij V, Fields JA, Bharti A, Achim CL, Moore DJ, Letendre SL. Antiretroviral drug concentrations in brain tissue of adult decedents. AIDS. 2020 Nov 1;34(13):1907-1914. doi: 10.1097/QAD.0000000000002628. PubMed PMID: 32694413; PubMed Central PMCID: PMC10768889.
Ojeda-Juárez D, Shah R, Fields JA, Harahap-Carrillo IS, Koury J, Maung R, Gelman BB, Baaten BJ, Roberts AJ, Kaul M. Lipocalin-2 mediates HIV-1 induced neuronal injury and behavioral deficits by overriding CCR5-dependent protection. Brain Behav Immun. 2020 Oct;89:184-199. doi: 10.1016/j.bbi.2020.06.016. Epub 2020 Jun 11. PubMed PMID: 32534984; PubMed Central PMCID: PMC8153086.
Ellis RJ, Diaz M, Sacktor N, Marra C, Collier AC, Clifford DB, Calcutt N, Fields JA, Heaton RK, Letendre SL. Predictors of worsening neuropathy and neuropathic pain after 12 years in people with HIV. Ann Clin Transl Neurol. 2020 Jul;7(7):1166-1173. doi: 10.1002/acn3.51097. Epub 2020 Jul 3. PubMed PMID: 32619341; PubMed Central PMCID: PMC7359117.
Fields JA, Swinton MK, Soontornniyomkij B, Carson A, Achim CL. Beta amyloid levels in cerebrospinal fluid of HIV-infected people vary by exposure to antiretroviral therapy. AIDS. 2020 Jun 1;34(7):1001-1007. doi: 10.1097/QAD.0000000000002506. PubMed PMID: 32073451; PubMed Central PMCID: PMC7210049.
Canchi S, Swinton MK, Rissman RA, Fields JA. Transcriptomic analysis of brain tissues identifies a role for CCAAT enhancer binding protein β in HIV-associated neurocognitive disorder. J Neuroinflammation. 2020 Apr 11;17(1):112. doi: 10.1186/s12974-020-01781-w. PubMed PMID: 32276639; PubMed Central PMCID: PMC7149918.
Fields JA, Swinton MK, Carson A, Soontornniyomkij B, Lindsay C, Han MM, Frizzi K, Sambhwani S, Murphy A, Achim CL, Ellis RJ, Calcutt NA. Tenofovir disoproxil fumarate induces peripheral neuropathy and alters inflammation and mitochondrial biogenesis in the brains of mice. Sci Rep. 2019 Nov 20;9(1):17158. doi: 10.1038/s41598-019-53466-x. PubMed PMID: 31748578; PubMed Central PMCID: PMC6868155.
Swinton MK, Carson A, Telese F, Sanchez AB, Soontornniyomkij B, Rad L, Batki I, Quintanilla B, Pérez-Santiago J, Achim CL, Letendre S, Ellis RJ, Grant I, Murphy AN, Fields JA. Mitochondrial biogenesis is altered in HIV+ brains exposed to ART: Implications for therapeutic targeting of astroglia. Neurobiol Dis.2019 Oct;130:104502. doi: 10.1016/j.nbd.2019.104502. Epub 2019 Jun 22. PubMed PMID: 31238091; PubMed Central PMCID: PMC6714553.
Fields JA, Ellis RJ. HIV in the cART era and the mitochondrial: immune interface in the CNS. Int Rev Neurobiol. 2019;145:29-65. doi: 10.1016/bs.irn.2019.04.003. Epub 2019 May 25. Review. PubMed PMID: 31208526.
Fields JA, Spencer B, Swinton M, Qvale EM, Marquine MJ, Alexeeva A, Gough S, Soontornniyomkij B, Valera E, Masliah E, Achim CL, Desplats P. Alterations in brain TREM2 and Amyloid-β levels are associated with neurocognitive impairment in HIV-infected persons on antiretroviral therapy. J Neurochem.2018 Dec;147(6):784-802. doi: 10.1111/jnc.14582. Epub 2018 Nov 26. PubMed PMID: 30152135; PubMed Central PMCID: PMC6310632.
Rozzi SJ, Avdoshina V, Fields JA, Mocchetti I. Human immunodeficiency virus Tat impairs mitochondrial fission in neurons. Cell Death Discov. 2018 Dec;4:8. doi: 10.1038/s41420-017-0013-6. eCollection 2018 Dec. PubMed PMID: 29531805; PubMed Central PMCID: PMC5841280.
Kesby JP, Fields JA, Chang A, Coban H, Achim CL, Semenova S. Effects of HIV-1 TAT protein and methamphetamine exposure on visual discrimination and executive function in mice. Behav Brain Res. 2018 Sep 3;349:73-79. doi: 10.1016/j.bbr.2018.04.046. Epub 2018 Apr 27. PubMed PMID: 29709610; PubMed Central PMCID: PMC6320247.
Kim C, Spencer B, Rockenstein E, Yamakado H, Mante M, Adame A, Fields JA, Masliah D, Iba M, Lee HJ, Rissman RA, Lee SJ, Masliah E. Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation. Mol Neurodegener. 2018 Aug 9;13(1):43. doi: 10.1186/s13024-018-0276-2. PubMed PMID: 30092810; PubMed Central PMCID: PMC6085656.
Thaney VE, Sanchez AB, Fields JA, Minassian A, Young JW, Maung R, Kaul M. Transgenic mice expressing HIV-1 envelope protein gp120 in the brain as an animal model in neuroAIDS research. J Neurovirol. 2018 Apr;24(2):156-167. doi: 10.1007/s13365-017-0584-2. Epub 2017 Oct 26. Review. PubMed PMID: 29075998; PubMed Central PMCID: PMC5911244.
Rozzi SJ, Avdoshina V, Fields JA, Trejo M, Ton HT, Ahern GP, Mocchetti I. Human Immunodeficiency Virus Promotes Mitochondrial Toxicity. Neurotox Res.2017 Nov;32(4):723-733. doi: 10.1007/s12640-017-9776-z. Epub 2017 Jul 10. Review. PubMed PMID: 28695547; PubMed Central PMCID: PMC5711529.
Divakaruni AS, Wallace M, Buren C, Martyniuk K, Andreyev AY, Li E, Fields JA, Cordes T, Reynolds IJ, Bloodgood BL, Raymond LA, Metallo CM, Murphy AN.Inhibition of the mitochondrial pyruvate carrier protects from excitotoxic neuronal death. J Cell Biol. 2017 Apr 3;216(4):1091-1105. doi: 10.1083/jcb.201612067. Epub 2017 Mar 2. PubMed PMID: 28254829; PubMed Central PMCID: PMC5379957.
Hategan A, Bianchet MA, Steiner J, Karnaukhova E, Masliah E, Fields A, Lee MH, Dickens AM, Haughey N, Dimitriadis EK, Nath A. HIV Tat protein and amyloid-β peptide form multifibrillar structures that cause neurotoxicity. Nat Struct Mol Biol. 2017 Apr;24(4):379-386. doi: 10.1038/nsmb.3379. Epub 2017 Feb 20. PubMed PMID: 28218748; PubMed Central PMCID: PMC5383535.
Fields JA, Metcalf J, Overk C, Adame A, Spencer B, Wrasidlo W, Florio J, Rockenstein E, He JJ, Masliah E. The anticancer drug sunitinib promotes autophagyand protects from neurotoxicity in an HIV-1 Tat model of neurodegeneration. J Neurovirol. 2017 Apr;23(2):290-303. doi: 10.1007/s13365-016-0502-z. Epub 2017 Jan 19. PubMed PMID: 28105557; PubMed Central PMCID: PMC5729903.
Valera E, Spencer B, Fields JA, Trinh I, Adame A, Mante M, Rockenstein E, Desplats P, Masliah E. Combination of alpha-synuclein immunotherapy with anti-inflammatory treatment in a transgenic mouse model of multiple system atrophy. Acta Neuropathol Commun. 2017 Jan 5;5(1):2. doi: 10.1186/s40478-016-0409-1. PubMed PMID: 28057080; PubMed Central PMCID: PMC5217191.
Fields JA, Overk C, Adame A, Florio J, Mante M, Pineda A, Desplats P, Rockenstein E, Achim C, Masliah E. Neuroprotective effects of the immunomodulatory drug FK506 in a model of HIV1-gp120 neurotoxicity. J Neuroinflammation. 2016 May 24;13(1):120. doi: 10.1186/s12974-016-0585-8. PubMed PMID: 27220536; PubMed Central PMCID: PMC4879748.
Avdoshina V, Fields JA, Castellano P, Dedoni S, Palchik G, Trejo M, Adame A, Rockenstein E, Eugenin E, Masliah E, Mocchetti I. The HIV Protein gp120 Alters Mitochondrial Dynamics in Neurons. Neurotox Res. 2016 May;29(4):583-593. doi: 10.1007/s12640-016-9608-6. Epub 2016 Mar 2. PubMed PMID: 26936603; PubMed Central PMCID: PMC4821687.
Fields JA, Serger E, Campos S, Divakaruni AS, Kim C, Smith K, Trejo M, Adame A, Spencer B, Rockenstein E, Murphy AN, Ellis RJ, Letendre S, Grant I, Masliah E. HIV alters neuronal mitochondrial fission/fusion in the brain during HIV-associated neurocognitive disorders. Neurobiol Dis. 2016 Feb;86:154-69. doi: 10.1016/j.nbd.2015.11.015. Epub 2015 Nov 22. PubMed PMID: 26611103; PubMed Central PMCID: PMC4713337.
Fields J, Dumaop W, Eleuteri S, Campos S, Serger E, Trejo M, Kosberg K, Adame A, Spencer B, Rockenstein E, He JJ, Masliah E. HIV-1 Tat alters neuronal autophagy by modulating autophagosome fusion to the lysosome: implications for HIV-associated neurocognitive disorders. J Neurosci. 2015 Feb 4;35(5):1921-38. doi: 10.1523/JNEUROSCI.3207-14.2015. PubMed PMID: 25653352; PubMed Central PMCID: PMC4315828.
Dhungel N, Eleuteri S, Li LB, Kramer NJ, Chartron JW, Spencer B, Kosberg K, Fields JA, Stafa K, Adame A, Lashuel H, Frydman J, Shen K, Masliah E, Gitler AD. Parkinson’s disease genes VPS35 and EIF4G1 interact genetically and converge on α-synuclein. Neuron. 2015 Jan 7;85(1):76-87. doi: 10.1016/j.neuron.2014.11.027. Epub 2014 Dec 18. PubMed PMID: 25533483; PubMed Central PMCID: PMC4289081.
Fields JA, Dumaop W, Crews L, Adame A, Spencer B, Metcalf J, He J, Rockenstein E, Masliah E. Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders. Curr HIV Res. 2015;13(1):43-54. doi: 10.2174/1570162×13666150311164201. Review. PubMed PMID: 25760044; PubMed Central PMCID: PMC4455959.
Nuber S, Tadros D, Fields J, Overk CR, Ettle B, Kosberg K, Mante M, Rockenstein E, Trejo M, Masliah E. Environmental neurotoxic challenge of conditional alpha-synuclein transgenic mice predicts a dopaminergic olfactory-striatal interplay in early PD. Acta Neuropathol. 2014 Apr;127(4):477-94. doi: 10.1007/s00401-014-1255-5. Epub 2014 Feb 8. PubMed PMID: 24509835; PubMed Central PMCID: PMC4324760.
Fields J, Dumaop W, Langford TD, Rockenstein E, Masliah E. Role of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disorders. J Neuroimmune Pharmacol. 2014 Mar;9(2):102-16. doi: 10.1007/s11481-013-9520-2. Epub 2014 Feb 8. Review. PubMed PMID: 24510686; PubMed Central PMCID: PMC3973421.
Fields J, Dumaop W, Adame A, Ellis RJ, Letendre S, Grant I, Masliah E. Alterations in the levels of vesicular trafficking proteins involved in HIV replication in the brains and CSF of patients with HIV-associated neurocognitive disorders. J Neuroimmune Pharmacol. 2013 Dec;8(5):1197-209. doi: 10.1007/s11481-013-9511-3. Epub 2013 Nov 30. PubMed PMID: 24292993; PubMed Central PMCID: PMC3973444.
Fields J, Cisneros IE, Borgmann K, Ghorpade A. Extracellular regulated kinase 1/2 signaling is a critical regulator of interleukin-1β-mediated astrocyte tissue inhibitor of metalloproteinase-1 expression. PLoS One. 2013;8(2):e56891. doi: 10.1371/journal.pone.0056891. Epub 2013 Feb 14. PubMed PMID: 23457635; PubMed Central PMCID: PMC3572966.
Fields J, Dumaop W, Rockenstein E, Mante M, Spencer B, Grant I, Ellis R, Letendre S, Patrick C, Adame A, Masliah E. Age-dependent molecular alterations in the autophagy pathway in HIVE patients and in a gp120 tg mouse model: reversal with beclin-1 gene transfer. J Neurovirol. 2013 Feb;19(1):89-101. doi: 10.1007/s13365-012-0145-7. Epub 2013 Jan 24. PubMed PMID: 23341224; PubMed Central PMCID: PMC3567331.
Fields J, Ghorpade A. C/EBPβ regulates multiple IL-1β-induced human astrocyte inflammatory genes. J Neuroinflammation. 2012 Jul 20;9:177. doi: 10.1186/1742-2094-9-177. PubMed PMID: 22818222; PubMed Central PMCID: PMC3464795.
Fields J, Gardner-Mercer J, Borgmann K, Clark I, Ghorpade A. CCAAT/enhancer binding protein β expression is increased in the brain during HIV-1-infection and contributes to regulation of astrocyte tissue inhibitor of metalloproteinase-1. J Neurochem. 2011 Jul;118(1):93-104. doi: 10.1111/j.1471-4159.2011.07203.x. Epub 2011 Mar 14. PubMed PMID: 21281310; PubMed Central PMCID: PMC3112278.
Kim MH, Fields J. Translationally regulated C/EBP beta isoform expression upregulates metastatic genes in hormone-independent prostate cancer cells.Prostate. 2008 Sep 1;68(12):1362-71. doi: 10.1002/pros.20801. PubMed PMID: 18512730.
Principle Investigator
Post Doctoral Fellows
Jacqueline Kulbe
M.D., Ph.D.
Post Doctoral Fellow
Bryant Avalos
Ph.D.
Post Doctoral Fellow
Ali Boustani
M.D.
Post Doctoral Fellow
Research Associates
Anna Laird
B.S.
Lab Coordinator | Research Associate
Mary Kelly Ford
B.S.
Research Associate
Undergraduate Researcher
Matthew Spencer
Undergraduate Researcher
Kyle Walter
Undergraduate Researcher
Leeann Shu
Undergraduate Researcher
Alumni
Anh Le, B.S.
Research Associate
Lauren Nguyen, B.S.
Undergraduate Researcher
Melody Sagarian, B.S.
Undergraduate Researcher
Ashley Olvera, B.S.
Undergraduate Researcher
Skylar Feick, B.S.
Undergraduate Researcher
Kaylie-Anna Vallee, B.S.
Research Associate
Mary Swinton, B.S
Research Associate
Interested in our research?
For more information about collaborations or available positions, please contact the Fields Lab at:
Principle Investigator Email
jafields@health.ucsd.edu
Lab Coordinator Email
alaird@health.ucsd.edu
Location
9500 Gilman Drive , La Jolla, CA 92193-0021 Biological Science Building, Room 303
Things we do together...
